UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007387
Receipt number R000008704
Scientific Title Clinical trials for long-term administration of sirolimus for lymphangioleiomyomatosis
Date of disclosure of the study information 2012/04/01
Last modified on 2020/03/04 09:27:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical trials for long-term administration of sirolimus for lymphangioleiomyomatosis

Acronym

Long-term administration of sirolimus for lymphangioleiomyomatosis

Scientific Title

Clinical trials for long-term administration of sirolimus for lymphangioleiomyomatosis

Scientific Title:Acronym

Long-term administration of sirolimus for lymphangioleiomyomatosis

Region

Japan


Condition

Condition

lymphangioleiomyomatosis

Classification by specialty

Pneumology Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify the efficacy and safety with long-term administration of sirolimus for lymphangioleiomyomatosis.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Symptoms, respiratory function, presence or absence of side effects after two years of administration

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

sirolimus

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

patients with lymphangioleiomyomatosis

Key exclusion criteria

pregnancy

Target sample size

1


Research contact person

Name of lead principal investigator

1st name yoshihiro
Middle name
Last name Nishimura

Organization

Kobe University Graduate School of Medicine

Division name

Division of Respiratiry Medicine

Zip code

6512102

Address

7-5-1 Kusunoki-cho, Chuo-ku, Kobe

TEL

078-382-5668

Email

nishiy@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name yoshihiro
Middle name
Last name Nishimura

Organization

Kobe University Graduate School of Medicine

Division name

Division of Respiratiry Medicine

Zip code

6512102

Address

7-5-1 Kusunoki-cho, Chuo-ku, Kobe

TEL

078-382-5668

Homepage URL


Email

nishiy@med.kobe-u.ac.jp


Sponsor or person

Institute

Kobe University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Division of Respiratiry Medicine, Kobe University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

none

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kobe Univ. Hospital Clinical Translational Research Center

Address

7-5-2 Kusunoki-cho, Chuo-ku, Kobe

Tel

078-382-6669

Email

chiken@med.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 04 Month 01 Day


Related information

URL releasing protocol

non

Publication of results

Unpublished


Result

URL related to results and publications

non

Number of participants that the trial has enrolled

1

Results

No adverse effects

Results date posted

2020 Year 03 Month 04 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

A LAM patient

Participant flow

NA

Adverse events

Nothing

Outcome measures

No adverse effects

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 03 Month 01 Day

Date of IRB

2015 Year 03 Month 31 Day

Anticipated trial start date

2012 Year 03 Month 31 Day

Last follow-up date

2015 Year 03 Month 31 Day

Date of closure to data entry

2015 Year 03 Month 31 Day

Date trial data considered complete

2015 Year 03 Month 31 Day

Date analysis concluded

2015 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2012 Year 02 Month 27 Day

Last modified on

2020 Year 03 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008704


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name